Ocrelizumab Intravenous and Sandostatin LAR Depot
Determining the interaction of Ocrelizumab Intravenous and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ocrelizumab Intravenous-Sandostatin LAR Depot injection
- Ocrelizumab Intravenous-Sani-Supp
- Ocrelizumab Intravenous-Sani-Supp rectal
- Ocrelizumab Intravenous-Sansert
- Ocrelizumab Intravenous-Santyl
- Ocrelizumab Intravenous-Saphris
- Sandostatin LAR Depot-Ocrevus
- Sandostatin LAR Depot-Octagam
- Sandostatin LAR Depot-Octagam Gammagard S/D
- Sandostatin LAR Depot-Octocaine
- Sandostatin LAR Depot-Octocaine 100
- Sandostatin LAR Depot-OctreoScan